Navigation Links
Transgenomic Announces Partnership With Key Genomics for Ovarian Cancer Assay to Guide Therapeutic Options
Date:9/16/2008

intended to provide the optimal therapy recommendation according to the molecular characteristics of each patient's tumor.

Tim Gallagher, Key Genomics CEO, said, "An algorithm that could quickly sort molecular information about a patient's particular tumor, and then match this information with the right drug treatment would be a valuable medical breakthrough. COXEN has the potential to bring significant healthcare and economic value by personalizing cancer therapy by using such a method, an algorithm based on in vitro response to anti-cancer drugs."

References

1. National Cancer Institute web site: http://www.cancer.gov/cancertopics/types/ovarian/

2. Lee JK et al. A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery. Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13086-91. Epub 2007 Jul 31.

About Transgenomic

Transgenomic is a global biotechnology company that provides unique products and services of automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of Pharmacogenomics and personalized medicine. Specific offerings include WAVE(R) DHPLC Systems, related consumables and assay kits, Cytogenetics automated systems, and Transgenomic Pharmacogenomics and Reference Laboratory Services. Transgenomic Pharmacogenomics and Laboratory Services utilize their technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and clinical laboratories, physicians and patients. For more information about the innovative systems, products and services offered by Tr
'/>"/>

SOURCE Transgenomic
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Transgenomic Reports Second Quarter 2008 Results
2. Reminder: Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast
3. Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast
4. Transgenomic Introduces SURVEYOR(R) Endonuclease Adaptor-Ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation
5. Webcast Alert: Transgenomic Inc. Announces First Quarter 2008 Earnings Release Conference Call Webcast
6. Transgenomic Opens Pharmacogenomics Laboratory in China
7. Reminder Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
8. Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
9. Transgenomic Appoints David Pauluzzi to Board of Directors
10. Transgenomic, Inc. Forms Scientific Advisory Board
11. Webcast Alert: Transgenomic Inc. Announces Third Quarter 2007 Earnings Release Conference Call Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)IRVINE, Calif., Dec. 4 BlueFire Ethanol Fuels, Inc. (OTC Bulletin Board: BFRE), a company focused on changing the world,s transportation fuel paradigm through the production of ethanol from non-food
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)TUSTIN, Calif., Dec. 3 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that it will release its financial results for the second quarter of fiscal year 2010 on December 10, 2009 at 7
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
Breaking Biology Technology:BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
...yrne Chapman, CIO of American Family When Byrne C...ly wasnt one of the variations he imagined. Yet th... taken him in just that direction. Byrne Chapmans ...rm data from the national weather service. , ,They...atch the predictions to the locations of their pol...
... Communications Inc., through its non-profit arm t...y-related grants to Wisconsin non-profits, the Bus...ty-four organizations that provide social services...ived money to help them use more technology. The g...ich typically gives from $2,500 to $25,000 per org...
...eres a great thing about the tech arena: even when...,Some number of them turn into start-up ventures (...fueled some other creative way). After some period...ts of jobs. In fact, small businesses create more ...hows no sign of slowing. , ,It can be appealing to...
Other Biology Technology:American Family CIO takes entrepreneurial approach to innovation 2American Family CIO takes entrepreneurial approach to innovation 3American Family CIO takes entrepreneurial approach to innovation 4How to duck the 3 most common entrepreneurial hiring traps 2How to duck the 3 most common entrepreneurial hiring traps 3How to duck the 3 most common entrepreneurial hiring traps 4
(Date:12/4/2009)Scientists from the Royal Botanic Gardens, Kew and the Natural History Museum believe that carnivorous behaviour in plants is far more widespread than previously thought, with many commonly grown plan
(Date:12/4/2009)This release is available in German . , A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing. Previou
(Date:12/4/2009)A major discovery is challenging accepted thinking about amyloids the fibrous protein deposits associated with diseases such as Alzheimer,s and Parkinson,s and may open up a potential new area for t
Breaking Biology News(10 mins):Scientists think 'killer petunias' should join the ranks of carnivorous plants 2How nutrition affects healthy aging 2New therapy targets for amyloid disease 2HemCon Medical Technologies Inc signs exclusive global agreement with Zimmer Dental Inc to distribute oral surgery dressings 57154 1HemCon Medical Technologies Inc signs exclusive global agreement with Zimmer Dental Inc to distribute oral surgery dressings 57154 2Hard To Treat Diseases 28HTDS 29 CUSIP Change to Force Short Sellers To Cover 57149 1Hard To Treat Diseases 28HTDS 29 CUSIP Change to Force Short Sellers To Cover 57149 2Hard To Treat Diseases 28HTDS 29 CUSIP Change to Force Short Sellers To Cover 57149 3Data From Multiple Clinical Trials of OrbusNeichs Genous 28TM 29 Bio engineered R stent 28TM 29 to be Presented at TCT 2009 5003 1Data From Multiple Clinical Trials of OrbusNeichs Genous 28TM 29 Bio engineered R stent 28TM 29 to be Presented at TCT 2009 5003 2Data From Multiple Clinical Trials of OrbusNeichs Genous 28TM 29 Bio engineered R stent 28TM 29 to be Presented at TCT 2009 5003 3
... of molecular signals that instructs cells with fa...53 tumor suppressor gene. If p53 is inactivated, a...and balances on cell growth fail to operate, and b...imately may lead to cancer. Not surprisingly, the ...d in great detail for many years but mainly in tis...
...ministration (FDA) announced the approval of Barac... treatment of chronic hepatitis B in adults. Chron...hepatitis B virus (HBV) that attacks the liver. Th...carring) of the liver, liver cancer, liver failure...Control and Prevention, approximately 1.25 million...
...st from the Virginia Commonwealth University Masse... at Memorial Sloan-Kettering Cancer Center, has id...lays a role in supplying nutrients to solid tumors...a greater understanding of the cell signaling that...lthy cells into helping to feed and spread growing...
Other Biology News:Cancer related gene p53 not regulated as indicated by previous tissue culture research 2Cancer related gene p53 not regulated as indicated by previous tissue culture research 3
...g System is a compact, versatile & modular instrum...cluding: Intracellular, Extracellular, Transducer...euroLog Case & Power Supply unit (NL900D) forms th... only powered by this unit, but wiring within the ...
Mouse Anti-Xenopus laevis Xenopus nuclear factor, xnf7 Antibody, Unconjugated from Developmental Studies Hybridoma Bank
PCAEC (P300-05) from European Collection of Cell Cultures (ECACC)
Goat Anti-Proliferin (N-14) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: